Dr. Mélina FATSEAS



Articles

2023

  1. Chapron, S-A.; Kervran, C.; Da Rosa, M.; Fournet, L.; Shmulewitz, D.; Hasin, D.; Denis, C.; Collombat, J.; Monsaingeon, M.; Fatseas, M.; Gatta-Cherifi, B.; Serre, F. et al. Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. In Drug and Alcohol Dependence, 251: 110937, 2023. doi 
  2. Chirokoff, V.; Dupuy, M.; Abdallah, M.; Fatseas, M.; Serre, F.; Auriacombe, M.; Misdrahi, D.; Berthoz, S.; Swendsen, J.; Sullivan, E. V. and Chanraud, S. Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders. In Addiction Neuroscience, 9: 100138, 2023. doi 
  3. Morawetz, C.; Berboth, S.; Chirokoff, V.; Chanraud, S.; Misdrahi, D.; Serre, F.; Auriacombe, M.; Fatseas, M. and Swendsen, J. Mood Variability, Craving, and Substance Use Disorders: From Intrinsic Brain Network Connectivity to Daily Life Experience. In Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 8 (9): 940-955, 2023. doi 

2022

  1. Egal, A.; Donon, C.; Jakubiec, L.; Lambert, L.; Fatseas, M. and Auriacombe, M. Ordalie, recherche de sensations et impulsivité. Analyse critique des définitions. In L'Encéphale, 48 (2): 163-170, 2022. doi 
  2. Jakubiec, L.; Chirokoff, V.; Abdallah, M.; Sanz-Arigita, E.; Dupuy, M.; Swendsen, J.; Berthoz, S.; Gierski, F.; Guionnet, S.; Misdrahi, D.; Serre, F.; Auriacombe, M. et al. The Executive Functioning Paradox in Substance Use Disorders. In Biomedicines, 10 (11): 2728, 2022. doi 

2021

  1. Dupuy, M.; Abdallah, M.; Swendsen, J.; N'Kaoua, B.; Chanraud, S.; Schweitzer, P.; Fatseas, M.; Serre, F.; Barse, E.; Auriacombe, M. and Misdrahi, D. Real-time cognitive performance and positive symptom expression in schizophrenia. In European Archives of Psychiatry and Clinical Neuroscience, 2021. doi 

2018

  1. Auriacombe, M.; Moriceau, S.; Serre, F.; Denis, C.; Micoulaud-Franchi, J-A.; de Sevin, E.; Bonhomme, E.; Bioulac, S.; Fatseas, M. and Philip, P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. In Drug and Alcohol Dependence, 193: 1-6, 2018. doi 
  2. Bouvard, A.; Dupuy, M.; Schweitzer, P.; Revranche, M.; Fatseas, M.; Serre, F.; Misdrahi, D.; Auriacombe, M. and Swendsen, J. Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls. In The American Journal on Addictions, 27 (7): 553-556, 2018. doi 
  3. Dupuy, M.; Misdrahi, D.; N'Kaoua, B.; Tessier, A.; Bouvard, A.; Schweitzer, P.; Auriacombe, M.; Serre, F.; Fatseas, M. and Swendsen, J. Mobile cognitive testing in patients with schizophrenia: A controlled study of feasibility and validity. In Journal de Thérapie Comportementale et Cognitive, 28 (4): 204-213, 2018. doi 
  4. Fatseas, M.; Serre, F.; Swendsen, J. and Auriacombe, M. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study. In Drug and Alcohol Dependence, 187: 242-248, 2018. doi 
  5. Serre, F.; Fatseas, M.; Denis, C.; Swendsen, J. and Auriacombe, M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. In Addictive Behaviors, 83: 123-129, 2018. doi 

2017

  1. Auriacombe, M.; Alexandre, J-M.; Dubernet, J.; Tanguy, J. and Fatseas, M. Contribution of e-learning to addiction teaching: A successful experience at the university of bordeaux, France. In Drug and Alcohol Dependence, 171: e12, 2017. doi 
  2. Denis, C. M.; da Rosa, M. A. C.; Serre, F.; Kervran, C.; Henry, M.; Cherifi, B.; Auriacombe, M. and Fatseas, M. Are DSM-5 criteria for sud transferable to food addiction? IRT analysis for alcohol, tobacco, cannabis, opiate and food addiction in a clinical sample. In Drug and Alcohol Dependence, 171: e52, 2017. doi 
  3. Fatseas, M.; Henry, M.; da Rosa, M. A. C.; Collombat, J.; Gregoire, A.; Kervran, C.; Cherifi, B. and Auriacombe, M. Eating disorder, food addiction and associated factors in obese patients. In Drug and Alcohol Dependence, 171: e62, 2017. doi 
  4. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. How psychiatric comorbidity and mood states influence craving and substance use in daily life? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorders. In Drug and Alcohol Dependence, 171: e187, 2017. doi 
  5. Techer, L.; Alexandre, J-M.; Mété, D.; Auriacombe, M. and Fatseas, M. Addictive behaviors and psychiatric comorbidities of incarcerated women in a French overseas territory. In Drug and Alcohol Dependence, 171: e201, 2017. doi 

2016

  1. Auriacombe, M; Serre, F and Fatseas, M Le craving : marqueur diagnostique et pronostique des addictions?. In Traité d'addictologie, 2016.
  2. Fatseas, M.; Alexandre, J-M.; Vénisse, J-L.; Romo, L.; Valleur, M.; Magalon, D.; Chéreau-Boudet, I.; Luquiens, A.; Guilleux, A.; JEU, G.; Challet-Bouju, G. and Grall-Bronnec, M. Gambling behaviors and psychopathology related to Attention-Deficit/Hyperactivity Disorder (ADHD) in problem and non-problem adult gamblers. In Psychiatry Research, 239: 232-238, 2016. doi 
  3. Fatseas, M.; Kervran, C. and Auriacombe, M. Troubles du sommeil et addictions : impact sur la qualité de vie et le risque de rechute. In La Presse Médicale, 45 (12): 1164-1169, 2016. doi 

2015

  1. Alexandre, J-M.; Fatseas, M.; Bouju, G.; Legauffre, C.; Valleur, M.; Magalon, D.; Chereau-Boudet, I.; Gorsane, M.; Auriacombe, M.; Hardouin, J.; Venisse, J. and Grall-Bronnec, M. Gambling behavior among gamblers with and without attention deficit/hyperactivity disorder. In Drug and Alcohol Dependence, 146: e205-e206, 2015. doi 
  2. Auriacombe, M.; Denis, C. M.; Rosa, M. A. C.; Collombat, J.; Serre, F.; Daulouede, J-P. and Fatseas, M. Validity of the eating section for the modified addiction severity index. In Drug and Alcohol Dependence, 156: e12, 2015. doi 
  3. Daulouède, J-P.; Denis, C. M.; Fatseas, M.; Beltran, V. and Auriacombe, M. Risk-taking behavior over 36-month follow-up treatment in outpatient opioid maintenance treatment program. In Drug and Alcohol Dependence, 146: e258, 2015. doi 
  4. Denis, C. M.; Fatseas, M.; Beltran, V.; Daulouede, J-P. and Auriacombe, M. Impact of 20 years harm reduction policy on HIV and HCV among opioid users not in treatment. In Drug and Alcohol Dependence, 146: e261, 2015. doi 
  5. Fatseas, M.; Collombat, J.; Rosa, M. A. C.; Denis, C. M.; Alexandre, J-M.; Debrabant, R.; Serre, F. and Auriacombe, M. Measuring “craving” in food addiction: Type, frequency, intensity. In Drug and Alcohol Dependence, 156: e66, 2015. doi 
  6. Fatseas, M; Hurmic, H.; Debrabant, R.; Serre, F and Auriacombe, M. Substance use patterns associated with adult ADHD in SUD treatment-seeking patients: Results from the aquitaine addiction cohort study. In Drug and Alcohol Dependence, 146: e274-e275, 2015. doi 
  7. Fatseas, M.; Serre, F.; Alexandre, J-M.; Debrabant, R.; Auriacombe, M. and Swendsen, J. Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues. In Addiction, 110 (6): 1035-1042, 2015. doi 
  8. Hurmic, H.; Debrabant, R.; Kervran, C.; Serre, F.; Auriacombe, M. and Fatseas, M. ADHD and substance use disorders: Subtype and gender differences. In Drug and Alcohol Dependence, 156: e100-e101, 2015. doi 
  9. Hurmic, H.; Debrabant, R.; Serre, F.; Fatseas, M.; Alix, M. and Auriacombe, M. Frequency and intensity of craving among addicted patients during outpatient treatment. In Drug and Alcohol Dependence, 146: e145, 2015. doi 
  10. Kervran, C.; Debrabant, R.; Taillard, J.; Philip, P.; Auriacombe, M. and Fatseas, M. Association between morningness/eveningness, addiction severity and psychiatric disorders among individuals with addictions. In Drug and Alcohol Dependence, 156: e108, 2015. doi 
  11. Kervran, C; Serre, F; Fatseas, M; Debrabant, R.; Trouba, C; Taillard, J; Philip, P and Auriacombe, M. Sleep quality in patients with SUD and behavioral addictions assessed by actigraphy: A prospective study. In Drug and Alcohol Dependence, 146: e156-e157, 2015. doi 
  12. Lhommeau, N.; Alexandre, J-M.; Mete, D.; Fatseas, M. and Auriacombe, M. Characteristics of gamblers choosing self-exclusion from casinos: A prospective study in a French overseas territory. In Drug and Alcohol Dependence, 156: e127, 2015. doi 
  13. Rosa, M. A. C.; Collombat, J.; Denis, C. M.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatseas, M. Overlap between food addiction and DSM-5 eating disorders in a treatment seeking sample. In Drug and Alcohol Dependence, 156: e192, 2015. doi 
  14. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Does craving intensity influence cue exposure reports? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorder. In Drug and Alcohol Dependence, 156: e201, 2015. doi 
  15. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Corrigendum to “Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review” Drug and Alcohol Dependence 148 (2015) 1–20. In Drug and Alcohol Dependence, 154: 305-314, 2015. doi 
  16. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review. In Drug and Alcohol Dependence, 148: 1-20, 2015. doi 

2014

  1. Auriacombe, M; Denis, C and Fatseas, M Commentary on Sharkow et al. (2014): Longitudinal patterns of problematic computer game use among adolescents and adults – a 2-year panel study. Welcomed and yet to come. Are we looking at what we are looking for?. In Addiciton, 2014.
  2. Auriacombe, M.; Denis, C. M.; Beltran, V.; Alexandre, J.; Debrabant, R.; Serre, F.; Daulouede, J-P. and Fatseas, M. 10-years outcome of methadone- and buprenorphine-maintained patients. Mortality, quality of life and substance use. In Drug and Alcohol Dependence, 140: e8, 2014. doi 
  3. Debrabant, R.; Fatseas, M.; Denis, C.; Taillard, J.; Philip, P. and Auriacombe, M. Qualité subjective du sommeil chez des sujets dépendants aux opiacés traités par méthadone ou buprénorphine. In Médecine du Sommeil, 11 (1): 34-35, 2014. doi 
  4. Fatseas, F; Debrabant, R and Auriacombe, M Usage de substances psychoactives et TDA/H. In Aide Mémoire des TDA/H à tous les âges, 2014.
  5. Gazel, C; Fatseas, M and Auriacombe, M Quels changements pour les addictions dans le DSM 5 ?. In La Lettre du Psychiatre, 10 (2): 50-53, 2014.
  6. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Does craving predict substance use for different substance use disorders? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin dependence. In Drug and Alcohol Dependence, 140: e202-e203, 2014. doi 
  7. Serre, F; Fatseas, M; Swendsen, J and Auriacombe, M Are sleep disturbances associated with craving intensity?: What is the influence of psychiatric comorbidity and type of substance on this relationship? A computerized ambulatory monitoring study in patients beginning treatment for addiction. In 76th College on Problems of Drug Dependence, 2014.
  8. van Emmerik-van Oortmerssen, K.; van de Glind, G.; Koeter, M. W J; Allsop, S.; Auriacombe, M.; Barta, C.; Bu, E. T. H; Burren, Y.; Carpentier, P-J.; Carruthers, S.; Casas, M.; Demetrovics, Z. et al. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. In Addiction, 109 (2): 262-272, 2014. doi 

2013

  1. Fatseas, M; Denis, C; Debrabant, R; Mathillon, V; Beltran, V; Daulouède, J P; Balducci, M and Auriacombe, M Changes in Sleep Quality in Opiate-Dependent Subjects in Methadone and Buprenorphine Maintenance Treatment over a 12-month period. In Heroin Addiction and Related Clinical Problems, 15 (1): 39-44, 2013.
  2. Sarram, S; Debrabant, R; Fatseas, M; Daulouede, J P; Sagaspe, P; Taillard, J; Philip, P; Auriacombe, M; S., S.; R., D.; M., F.; J.P., D. et al. Changes in sleep quality and alertness in opiate-dependent subjects after stable methadone and buprenorphine maintenance treatment. A pilot exploratory report. In Heroin Addiction and Related Clinical Problems, 15 (1): 39-44, 2013.

2012

  1. Alexandre, J-M.; Fatseas, M and Auriacombe, M Addiction(s)?. In Biofutur, 338: 27-29, 2012.
  2. Fatseas, M.; Debrabant, R. and Auriacombe, M. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. In Current Opinion in Psychiatry, 25 (3): 219-225, 2012. doi 
  3. Fatseas, M.; Denis, C.; Serre, F.; Dubernet, J.; Daulouède, J-P. and Auriacombe, M. Change in HIV-HCV Risk-Taking Behavior and Seroprevalence Among Opiate Users Seeking Treatment Over an 11-year Period and Harm Reduction Policy. In AIDS and Behavior, 16 (7): 2082-2090, 2012. doi 
  4. Serre, F; Denis, C; Fatseas, M and Auriacombe, M Santé, travail et addiction. In Le Courrier des Addictions, 14: 22-23, 2012.
  5. Serre, F.; Fatseas, M.; Debrabant, R.; Alexandre, J-M.; Auriacombe, M. and Swendsen, J. Ecological momentary assessment in alcohol, tobacco, cannabis and opiate dependence: A comparison of feasibility and validity. In Drug and Alcohol Dependence, 126 (1-2): 118-123, 2012. doi 

2011

  1. Fatseas, M.; Denis, C.; Massida, Z.; Verger, M.; Franques-Rénéric, P. and Auriacombe, M. Cue-Induced Reactivity, Cortisol Response and Substance Use Outcome in Treated Heroin Dependent Individuals. In Biological Psychiatry, 70 (8): 720-727, 2011. doi 

Collections

2015

  1. Fatseas, M.; Dubernet, J.; Daoulouède, J-P. and Auriacombe, M. Buprenorphine in the Treatment of Opioid Addiction: The French Experience. In Textbook of Addiction Treatment: International Perspectives, pages 501-510, Springer Milan, Milano, 2015.

2013

  1. Denis, C.; Lavie, E.; Fatseas, M. and Auriacombe, M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. In Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd, Chichester, UK, 2013.

2012

  1. Fatseas, M; Denis, C; Alexandre, J-M. and Auriacombe, M Les critères diagnostiques de la dépendance aux substances psycho-actives sont-ils valides pour le diagnostic du jeu pathologique ?. In Le jeu pathologique. Comprendre-Prévenir-Traiter, pages 101-105, Masson, Paris, Congrès de psychiatrie et de neurologie de langue française , 2012.

In Proceedings

2013

  1. Fatseas, M; Serre, F; Swendsen, J and Auriacombe, M Does cue type matter for Craving?: Comparison of substance-specific and person-specific cues using mobile technologies. In 75th College on Problems of Drug Dependence, 2013.
  2. Serre, F; Fatseas, M; M., S J and Auriacombe, M Does craving predict substance use for different substance use disorders?: Ecological Momentary Assessment in alcohol, tobacco, cannabis and heroin dependence. In 75th College on Problems of Drug Dependence, 2013.
  3. Swendsen, J; Serre, F; Fatseas, M and Auriacombe, M A systematic review of studies exploring craving, its moderators, and the link with substance use in daily life using Ecological Momentary Assessment (EMA). In 75th College on Problems of Drug Dependence, 2013.

2012

  1. Fatseas, M; Serre, F; Swendsen, J and Auriacombe, M Relationships between sleep disturbances and variations of craving in patients beginning treatment for addiction: a computerized ambulatory monitoring study. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.
  2. Quintin, J; Serre, F; Fatseas, M; Auriacombe, S and Auriacombe, M Relationships between decision making, type of addiction, and addiction severity. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.
  3. Serre, F; Swendsen, J; Fatseas, M and Auriacombe, M Feasibility and validity of Ecological Momentary Assessment in alcohol, tobacco, cannabis and opiates dependent patients. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.

 

 

 


Université de Bordeaux CNRS

CNRS UMR 6033


Participez à une étude...

A noter

Ecrans et addictions : interviews d'avril

Directeur

Pr. Marc Auriacombe

Directeur adjoint

J. Taillard

Administration :

Tel : +33 (0)5 57 82 01 73

Bureau Recherche Sommeil

Tel : +33 (0)5 57 82 01 82

Bureau Recherche Addiction

Tel : +33 (0)5 56 56 17 67

Adresse :

UMR 6033 SANPSY
CHU Pellegrin, Tripode
13ème étage, aile 3
Place Amélie- Raba-Léon
33076 Bordeaux cédex
France

logo SANPSY Accéder au laboratoire

Investissement d'Avenir Clinilabs Certified Site Clinilabs Certified Site